Early treatment of MS leads to decrease in total costs

Best Practice Nordic | Sep 2019 | ECTRIMS 2019 |

A larger decrease in total costs was observed in patients with MS who received their first disease modifying therapies early, which could potentially be explained by a slower disease progression leading to maintained work capacity.